TP53
MOLECULAR TARGETtumor protein p53
TP53 (tumor protein p53) is targeted by 151 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting TP53
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 151 compounds. Use the BiohacksAI search to explore all TP53 modulators.
About TP53 as a Drug Target
TP53 (tumor protein p53) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 151 compounds with documented TP53 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
TP53 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.